Tribunal decision: Revenue's appeal dismissed, assessee partly successful. Key issues: corporate guarantee, ESOP, ALP.

The Tribunal dismissed the Revenue's appeal and partly allowed the assessee's appeal. The Tribunal upheld the Ld. CIT(A)'s decisions regarding the corporate guarantee, ESOP expenditure, and ALP for loans. Additionally, the Tribunal directed the A.O. to verify and allocate expenses properly for public conferences, corporate overheads, ESOP, and R&D expenditure.

---

---

Issues Involved:
1. Corporate Guarantee as an International Transaction
2. Expenditure on Employee Stock Options (ESOPs)
3. Determination of Arm's Length Price (ALP) for Loans to Associated Enterprises (AEs)
4. Treatment of Expenditure for Repairs and Maintenance
5. Deductibility of Expenses Incurred for Public Conferences
6. Allocation of Corporate Overheads, ESOP, and R&D Expenditure to Units Eligible for Deduction

Issue-wise Detailed Analysis:

1. Corporate Guarantee as an International Transaction:
The Revenue contended that the corporate guarantee provided by the assessee to its foreign AEs should be considered an international transaction under section 92B of the Income Tax Act, 1961, warranting an ALP adjustment. The Assessing Officer (A.O.) made a TP adjustment by charging a 2% commission on the guarantee, resulting in an addition of Rs. 26.34 Crs. The Ld. CIT(A) followed the assessee's own case rulings for earlier years, concluding that the corporate guarantee is not an international transaction as per section 92B, and hence, no ALP adjustment is warranted. The Tribunal upheld the Ld. CIT(A)'s decision, rejecting the Revenue's grounds.

2. Expenditure on Employee Stock Options (ESOPs):
The Revenue argued that the ESOP expenditure is not an ascertained liability and hence not allowable as revenue expenditure. The Ld. CIT(A) observed that this issue was previously considered in the assessee's favor, treating the ESOP expenditure as an ascertained liability and allowable under section 37(1). The Tribunal upheld the Ld. CIT(A)'s decision, rejecting the Revenue's ground.

3. Determination of Arm's Length Price (ALP) for Loans to Associated Enterprises (AEs):
The A.O. determined the ALP for loans given to AEs using an interest rate of 7%, resulting in an adjustment of Rs. 6.50 Crs. The Ld. CIT(A) and the ITAT in earlier years adopted LIBOR + 200 basis points as the ALP. The Tribunal upheld the Ld. CIT(A)'s direction to adopt LIBOR + 200 basis points for the relevant years, rejecting the assessee's grounds.

4. Treatment of Expenditure for Repairs and Maintenance:
The assessee did not press this ground, and the Tribunal upheld the Ld. CIT(A)'s order rejecting the claim for repairs and maintenance expenditure.

5. Deductibility of Expenses Incurred for Public Conferences:
The assessee contended that expenses for doctors attending public conferences should be allowed as business expenses under section 37(1). The Tribunal directed the A.O. to verify the nature of the expenditure and disallow only those not incurred for business purposes, consistent with earlier years' rulings.

6. Allocation of Corporate Overheads, ESOP, and R&D Expenditure to Units Eligible for Deduction:
The assessee argued against allocating gross corporate overheads to units eligible for deduction under section 80-IC. The Tribunal directed the A.O. to allocate only net expenditure based on turnover, consistent with earlier years' rulings. For ESOP and R&D expenditure, the Tribunal, following the Bombay High Court's decision in Zandu Pharmaceutical Works Ltd, held that these should not be allocated to exempt units unless a direct nexus is established. The Tribunal concluded that the Tax Authorities were not justified in apportioning R&D and ESOP costs to units claiming deductions under sections 10B, 80IB, and 80IC.

Conclusion:
The appeal filed by the Revenue was dismissed, and the appeal filed by the assessee was partly allowed. The Tribunal upheld the Ld. CIT(A)'s decisions on corporate guarantee, ESOP expenditure, and ALP for loans, while directing the A.O. to verify and allocate expenses appropriately for public conferences, corporate overheads, ESOP, and R&D expenditure.

---